1. Aagaard H, Malpani R, Zorzet A (2021) Ensuring sustainable access to effective antibiotics for everyone, everywhere—how to address the global crisis in antibiotic Research and Development Retrieved from https://www.reactgroup.org/news-and-views/newsandopinions/year-2021/new-react-report-governments-need-to-take-more-leadershiptoensure-global-sustainable-access-to-effective-antibiotics/
2. Ackers L, Ackers-Johnson G, Welsh J, Kibombo D, Opio S (2020) Infection Prevention Control (IPC) and Antimicrobial Resistance (AMR). Anti-Microbial Resistance in Global Perspective, 53–80. https://doi.org/10.1007/978-3-030-62662-4_4
3. Adam M (2005) Integrating research and development: the emergence of rational drug design in the pharmaceutical industry. Stud Hist Philos Biol Biomed Sci 36(3):513–537. https://doi.org/10.1016/j.shpsc.2005.07.003
4. Åkerfeldt K, Svensson AC (2023) Identifying key bottlenecks in the early stages of antibiotic R&D and exploring public and not-for-profit solutions. ReAct Europe. https://www.reactgroup.org/wp-content/uploads/2023/03/ReAct-Expert-PolicyBriefbottlenecks-iearly-stages-antibiotic-RD-and-public-not-for-profit-solutionsReActEurope-13-March-2023-webb.pdf
5. Brives C, Rest M, Sariola S (2021) With microbes. Mattering Press, Manchester